Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

Affera Integrated Mapping System

K-Number: K243892 · 2025-01-17

Decision Date2025-01-17
Product CodeDQK
Advisory CommitteeCV
DecisionSubstantially Equivalent

Device Summary

Affera Integrated Mapping System is a medical device manufactured by Medtronic, Inc.. It received FDA 510(k) clearance on 2025-01-17 under approval number K243892. The device is classified under product code DQK. It was reviewed by the CV advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the Affera Integrated Mapping System?

Affera Integrated Mapping System is a medical device that received FDA 510(k) clearance on 2025-01-17. It is manufactured by Medtronic, Inc.. The 510(k) number is K243892.

When was Affera Integrated Mapping System approved by the FDA?

Affera Integrated Mapping System received FDA 510(k) clearance on 2025-01-17, under approval number K243892.

What company makes Affera Integrated Mapping System?

Affera Integrated Mapping System is manufactured by Medtronic, Inc..

What is the FDA product code for Affera Integrated Mapping System?

The FDA product code for Affera Integrated Mapping System is DQK.

Related Clinical Trials

Related PubMed Literature

Other Devices by Medtronic, Inc.

View all 137 devices →

Related Devices (Code: DQK)

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.